Steglatro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications or in addition to other medicinal products for the treatment of diabetes.
Ertugliflozin
Ipragliflozin
Linagliptin
Liraglutide
Exenatide
Vildagliptin
Saxagliptin
Sitagliptin